Literature DB >> 31044514

Heart failure prevention with sodium-glucose cotransporter 2 inhibitors.

Muhammad Shahzeb Khan1, Javed Butler2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31044514      PMCID： PMC6592728          DOI： 10.1111/1753-0407.12932

Source DB:  PubMed          Journal:  J Diabetes        ISSN： 1753-0407            Impact factor:   4.006


× No keyword cloud information.
  24 in total

1.  Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes: A Network Meta-Analysis.

Authors:  Caroline K Kramer; Chang Ye; Sara Campbell; Ravi Retnakaran
Journal:  JACC Heart Fail       Date:  2018-09-05       Impact factor: 12.035

2.  Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis.

Authors:  Kåre I Birkeland; Marit E Jørgensen; Bendix Carstensen; Frederik Persson; Hanne L Gulseth; Marcus Thuresson; Peter Fenici; David Nathanson; Thomas Nyström; Jan W Eriksson; Johan Bodegård; Anna Norhammar
Journal:  Lancet Diabetes Endocrinol       Date:  2017-08-03       Impact factor: 32.069

3.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; Christoph Wanner; John M Lachin; David Fitchett; Erich Bluhmki; Stefan Hantel; Michaela Mattheus; Theresa Devins; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

Review 4.  Cardiovascular Protection by Sodium Glucose Cotransporter 2 Inhibitors: Potential Mechanisms.

Authors:  Bart Staels
Journal:  Am J Med       Date:  2017-06       Impact factor: 4.965

Review 5.  Endothelial dysfunction, arterial stiffness, and heart failure.

Authors:  Catherine N Marti; Mihai Gheorghiade; Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Arshed A Quyyumi; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2012-09-19       Impact factor: 24.094

Review 6.  Remodeling of calcium handling in human heart failure.

Authors:  Qing Lou; Ajit Janardhan; Igor R Efimov
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

7.  Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

Authors:  Bruce Neal; Vlado Perkovic; Kenneth W Mahaffey; Dick de Zeeuw; Greg Fulcher; Ngozi Erondu; Wayne Shaw; Gordon Law; Mehul Desai; David R Matthews
Journal:  N Engl J Med       Date:  2017-06-12       Impact factor: 91.245

8.  Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54.

Authors:  Deepak L Bhatt; Marc P Bonaca; Sameer Bansilal; Dominick J Angiolillo; Marc Cohen; Robert F Storey; Kyungah Im; Sabina A Murphy; Peter Held; Eugene Braunwald; Marc S Sabatine; Ph Gabriel Steg
Journal:  J Am Coll Cardiol       Date:  2016-04-01       Impact factor: 24.094

9.  Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus.

Authors:  Karin Rådholm; Gemma Figtree; Vlado Perkovic; Scott D Solomon; Kenneth W Mahaffey; Dick de Zeeuw; Greg Fulcher; Terrance D Barrett; Wayne Shaw; Mehul Desai; David R Matthews; Bruce Neal
Journal:  Circulation       Date:  2018-07-31       Impact factor: 29.690

10.  Secular changes in the age-specific prevalence of diabetes among U.S. adults: 1988-2010.

Authors:  Yiling J Cheng; Giuseppina Imperatore; Linda S Geiss; Jing Wang; Sharon H Saydah; Catherine C Cowie; Edward W Gregg
Journal:  Diabetes Care       Date:  2013-05-01       Impact factor: 19.112
View more
  1 in total

Review 1.  Sodium-Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes.

Authors:  Muhammad Shahzeb Khan; Javed Butler
Journal:  Card Fail Rev       Date:  2019-11-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.